A detailed history of Kennedy Capital Management, Inc. transactions in Dexcom Inc stock. As of the latest transaction made, Kennedy Capital Management, Inc. holds 47,528 shares of DXCM stock, worth $3.81 Million. This represents 0.07% of its overall portfolio holdings.

Number of Shares
47,528
Previous 20,766 128.87%
Holding current value
$3.81 Million
Previous $2.35 Million 35.3%
% of portfolio
0.07%
Previous 0.05%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$64.0 - $116.06 $1.71 Million - $3.11 Million
26,762 Added 128.87%
47,528 $3.19 Million
Q2 2024

Aug 14, 2024

BUY
$110.31 - $140.45 $946,901 - $1.21 Million
8,584 Added 70.46%
20,766 $2.35 Million
Q1 2024

May 15, 2024

BUY
$114.22 - $140.1 $1.39 Million - $1.71 Million
12,182 New
12,182 $1.69 Million

Others Institutions Holding DXCM

About DEXCOM INC


  • Ticker DXCM
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 386,257,984
  • Market Cap $31B
  • Description
  • DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems in the United States and internationally. The company provides its systems for use by people with diabetes, as well as for use by healthcare providers. Its products include DexCom G6, an integrated CGM ...
More about DXCM
Track This Portfolio

Track Kennedy Capital Management, Inc. Portfolio

Follow Kennedy Capital Management, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Kennedy Capital Management, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Kennedy Capital Management, Inc. with notifications on news.